| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8447915 | European Journal of Cancer | 2010 | 7 Pages |
Abstract
The recommended phase II dose in children is TMZ 150Â mg/m2 on days 1-5 and VP-16 50Â mg/m2 on days 1-10 every 28Â d. The combination was well tolerated and demonstrated antitumour activity.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Antonio Ruggiero, Daniela Rizzo, Giorgio Attinà , Ilaria Lazzareschi, Stefano Mastrangelo, Palma Maurizi, Roberta Migliorati, Patrizia Bertolini, Maria Pastore, Cesare Colosimo, Riccardo Riccardi,